Introduction to Pharmaceuticals

  • Keshav S. Moharir
  • Vinita V. Kale
  • Abhay M. Ittadwar
  • Y. V. PathakEmail author
Living reference work entry


The origin of medicine dates back to prehistoric era with use of crude, natural compounds in the beginning. Development in discoveries was gradual with increase in natural sources of medicines followed by generation of new scientific theories and principles. The chronological journey leads us today to astonishing developments in terms of new dosage forms, drug delivery systems, and surgical procedures. The further progress is predicted to occur only with extensive interdisciplinary studies and proper application of technological advances.

The fields of studies in every aspect have grown in the last two centuries by leaps and bounds, and space explorations are not left behind. Once upon a time, man thought of landing on moon, and the day man landed the moon was 20 July 1969. Similarly, a day will come he will land on Mars, and maybe space tourism will flourish soon. The inevitable part here is use of medicines in space. Space environment poses different set of challenges that need extensive research. The present discussion talks about various studies for maintaining stability, efficacy, and safety and extending shelf life of medicines for astronauts working in spaceflights. We have some information on short-time space travels, but data for effects of long-term travel in space is missing. So also if a common man travels to space, the requirements will be significantly different from those of the present-day trained astronaut travel. The previous experience of astronauts and available data of these studies, both in space and simulated environment on Earth, set tone for further approaches which will give assurance of stability of medicines in space.


  1. Akbarzadeh A, Rezaei-Sadabady R et al (2013) Liposome; classification, preparation and applications. Nanoscale Res Lett 8(1):102CrossRefGoogle Scholar
  2. Allen LV Jr, Ansel HC (2014a) Ansel’s pharmaceutical dosage forms and drug delivery systems, 10th edn. Lippincott Williams & Wilkins, Baltimore, pp 4–7Google Scholar
  3. Allen LV Jr, Ansel HC (2014b) Ansel’s pharmaceutical dosage forms and drug delivery systems, 10th edn, chapter 1. Lippincott Williams & Wilkins, Baltimore, pp 2–4Google Scholar
  4. Allen LV Jr (2012) The art, science and technology of pharmaceutical compounding, 4th edn. American Pharmaceutical Association, Washington, DCGoogle Scholar
  5. Augsburger LL (1988) Instrumented capsule filling machines: methodology and application to product development. STP Pharma 4:116–122Google Scholar
  6. Banker GS (2002) Modern pharmaceutics, 4th edn, chap 1. Marcel Dekker, Inc., New York, pp 1–7Google Scholar
  7. Barratt M (1999) Medical support for the International Space Station. Aviat Space Environ Med 70:155–161PubMedGoogle Scholar
  8. Bhagwat RR, Vaidhya IS (2013) Novel drug delivery systems: an overview. Int J Pharm Sci Res 4(3):970–982Google Scholar
  9. Chien YW (1991) Novel drug delivery system, 2nd edn. CRC Press, Boca RatonCrossRefGoogle Scholar
  10. Christensen NJ, Drummer C, Norsk P (2001) Renal and sympathoadrenal responses in space. Am J Kidney Dis 38:679–683CrossRefGoogle Scholar
  11. Chuong MC (2011) Stability of vitamin B complex in multivitamin and multimineral supplement tablets after space flight. J Pharm Biomed Anal 55:1197–1200CrossRefGoogle Scholar
  12. College of Pharmacy and Pharmaceutical Sciences History (2018) Data from
  13. Crucian B, Stowe R, Mehta S et al (2013) Immune system dysregulation occurs during short duration space flights on board the space shuttle. J Clin Immunol 33:456–465CrossRefGoogle Scholar
  14. D’Aunno DS, Dougherty AH, DeBlock HF et al (2003) Effect of short and long-duration spaceflight on QTc intervals in healthy astronauts. Am J Cardiol 91:494–497CrossRefGoogle Scholar
  15. Dantuma D, Elmaddawi R, Pathak Y, Grenha A, de Oliveira R, Paludo C, dos Santos M (2015) Impact of simulated microgravity on nanoemulsion stability – a preliminary research. Am J Med Biol Res 3:102–106. Scholar
  16. Du B et al (2011) Evaluation of physical and chemical changes in pharmaceuticals flown on space missions. AAPS J 13(2):299–308CrossRefGoogle Scholar
  17. Florence AT, Attwood D (2006) Physicochemical principles of pharmacy, 4th edn. Pharmaceutical Press, LondonGoogle Scholar
  18. Homick JL, Reschke MF, Vanderploeg JM (1984) Space adaptation syndrome. Incidence and operational implications for the space, transportation system program. In: Motion sickness: mechanisms, prediction, prevention, and treatment, CP-372. Advisory Group for Aerospace Research, WilliamsburgGoogle Scholar
  19. Hoson T et al (1997) Evaluation of three dimensional clinostat as a simulator of weightlessness. Planta 203:187–197CrossRefGoogle Scholar
  20. Huntoon CSL, Cintron NM (1996) Endocrine system and fluid and electrolyte balance. In: Nicogossian AE, Gazenko OG (eds) Space biology and medicine, Joint US/Russian publication in five volumes, vol 3, book 1. AIAA, Reston, pp 89–104Google Scholar
  21. Johnson PC (1983) The erythropoietic effects of weightlessness. In: CDR D (ed) Current concepts in erythropoiesis. Wiley, New York, pp 279–300Google Scholar
  22. Kast J, Yu Y, Seubet CN, Wotring VE, Derendorf H (2017) Drugs in space: pharmacokinetics and pharmacodynamics in astronauts. Eur J Pharm Sci 109:52–58CrossRefGoogle Scholar
  23. Kovachevich IV et al (2009) Pharmacokinetics of acetaminophen administered in tablets and capsules under long-term space flight conditions. Pharm Chem J 43(3):130–134CrossRefGoogle Scholar
  24. Mahato RI, Narang AS (2012) Pharmaceutical dosage form and drug delivery, 2nd edn. CRC Press, Boca RatonGoogle Scholar
  25. Marshburn TH (2008) Acute care. In: Barratt MR, Pool SL (eds) Principles of clinical medicine for space flight, 1st edn. Springer, New York, pp 101–122CrossRefGoogle Scholar
  26. Martin DS, South DA, Wood ML et al (2002) Comparison of echocardiographic changes after short- and long-duration spaceflight. Aviat Space Environ Med 73:532–536PubMedGoogle Scholar
  27. Mehta P (2017) Impact of space environment on stability of medicines: challenges and prospects. J Pharm Biomed Anal 136:111–119CrossRefGoogle Scholar
  28. Mirza AZ, Siddiqui FA (2014) Nanomedicine and drug delivery: a mini review. Int Nano Lett 4:94CrossRefGoogle Scholar
  29. Narang AS, Rao VM, Raghavan K (2009) Excipient compatibility. In: Qiu Y, Chen Y, GGZ Z, Liu L, Porter W (eds) Developing solid oral dosage forms: pharmaceutical theory and practice. Elsevier, Burlington, pp 125–146CrossRefGoogle Scholar
  30. Oganov VS, Schneider VS (1996) Skeletal system. In: Nicogossian AE, Gazenko OG (eds) Space biology and medicine, Joint US/Russian publication in five volumes, vol 3, book 1. AIAA, Reston, pp 247–66Google Scholar
  31. Pathak Y, Thassu D (2009) Drug delivery nanoparticles formulation and characterization, 1st edn. Informa Healthcare, New YorkGoogle Scholar
  32. Putcha L (2011) Biopharmaceutical challenges of therapeutics in space: formulation and packaging considerations. Ther Deliv 2(11):1373–1376CrossRefGoogle Scholar
  33. Putcha L, Berens KL, Marshburn TH, Ortega HJ, Billica RD (1999) Pharmaceutical use by U.S. astronauts on space shuttle missions. Aviat Space Environ Med 70:705–708PubMedGoogle Scholar
  34. Shelley Chambers Fox (2014) Remington education – pharmaceutics, 1st edn, Chapters 9 and 13. Pharmaceutical Press, LondonGoogle Scholar
  35. Stewart LH, Trunkey D, Rebagliati GS (2007) Emergency medicine in space. J Emerg Med 32(1):45–54CrossRefGoogle Scholar
  36. Subramanyan CVS (2000) Textbook of physical pharmaceutics, 2nd edn. Vallabh Prakashan, Delhi, pp 366–394Google Scholar
  37. Talor GR, Konstantinova IV, Sonnenfeld G et al (1997) Changes in the immune system during and after spaceflight. Adv Space Biol Med 6:1–32CrossRefGoogle Scholar
  38. Tavassoli M (1986) Medical problems of space flight. Am J Med 81(5):850–854CrossRefGoogle Scholar
  39. Wing PC, Tsang IKY, Susack L et al (1991) Back pain and spinal changes in microgravity. Orthop Clin North Am 22:255–256PubMedGoogle Scholar
  40. Wotring VE (2015) Medication use by U.S. crewmembers on the International Space Station. FASEB J 29:4417–4423CrossRefGoogle Scholar
  41. Wotring VE (2016) Chemical potency and degradation products of medications stored over 550 Earth days at the International Space Station. AAPS J 18(1):210–216CrossRefGoogle Scholar
  42. Yalkowsky SH, Bolton S (1990) Particle size and content uniformity. Pharm Res 7:962–966CrossRefGoogle Scholar
  43. Yazhgur P et al (2015) How antifoams act: a microgravity study. npj Microgr 1(1):15004CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Keshav S. Moharir
    • 1
  • Vinita V. Kale
    • 1
  • Abhay M. Ittadwar
    • 1
  • Y. V. Pathak
    • 2
    • 3
    • 4
    Email author
  1. 1.Gurunanak College of PharmacyNagpurIndia
  2. 2.College of PharmacyUniversity of South FloridaTampaUSA
  3. 3.Faculty of PharmacyAirlangga UniversitySurabayaIndonesia
  4. 4.USF Health Taneja College of PharmacyUniversity of South FloridaTampa USA

Section editors and affiliations

  • Yashwant Pathak
    • 1
  1. 1.Health College of PharmacyUniversity of South FloridaTampaUSA

Personalised recommendations